1. I 2. II 3. STATEMENT OF INTENTThis guideline was developed to be a guide for best clinical practicein the management of dyslipidaemia. It is based on the bestavailable…

Slide 1Dyslipidemia and Cardiovascular Risk Reduction: An Evidence-Based Review Robert M. Guthrie, MD Professor of Emergency Medicine Professor of Internal Medicine Professor…

1.Dasdo A Sinaga Cardiologist 2. SECONDARY PREVENTION PRIMARY PREVENTION: To prevent cardiovascular event in patients without evidence of cardiovascular disease RISK FACTORS…

1. Assurance ofCardiovascular Risk Reduction comes from broad Clinical Experience 2. GALAXY Presentation - suggested execution 1 3. Is Lower Better?Relationship between LDL-C…

1. By Dr Mujahidah Naim 2.   3. Introduction Atherosclerosis cause by hypercholesterolemia, smoking, an elevated blood pressure and inflammation. 4.   5.   6.   7.  …

Hyperlipidemia Michele Ritter, M.D. Argy Resident â February, 2007 The story of lipids Chylomicrons transport fats from the intestinal mucosa to the liver In the liver,…

1. A soft waxy substance found among lipids (fats) in the bloodstream and all cells Needed for digesting fats, making hormones, building cell walls Carried in particles…

Slide 1 HDL: Still a target for therapy? PaACC Annual Chapter Meeting November 2, 2008 Daniel J. Rader, MD University of Pennsylvania School of Medicine [email protected]…

Slide 1This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud University.…

Slide 1 Evidence Based Secondary Prevention Christopher Cannon, M.D. TIMI Study Group Cardiovascular Division Brigham and Women’s Hospital Boston, MA Slide 2 Presenter…